Brazil faces new wave of pandemic amid shortage of COVID-19 vaccines
10 mins read

Brazil faces new wave of pandemic amid shortage of COVID-19 vaccines

Amid the new wave of the COVID-19 pandemic worldwide, Brazil has seen a steady increase in the number of cases of the new coronavirus in recent weeks. This is the second wave of the pandemic this year in the country.

Brazil faces new wave of pandemic amid shortage of COVID-19 vaccines
COVID vaccinations in the city of Eldorado do Sul (RS), June 2024 (Photo: Marinha do Brasil / CC BY 2.0)

According to vastly underestimated data from the Ministry of Health of the government of Brazilian President Luiz Inácio Lula da Silva (Workers’ Party – PT), COVID-19 deaths rose from 229 in July to 334 in August, while cases more than doubled during that period, from 17,964 to 36,970. The increase was also identified by the Todos pela Saúde Institute (ITpS), which noted that the test positivity rate reached 23 percent in mid-August, an increase of 10 percentage points in one month.

Cases continued to rise in September. Data released Thursday showed that COVID-19 cases rose from 7,180 in the epidemiological week of August 25 to 31 to 16,722 from September 1 to 7, while deaths fell from 89 to 62 during the same period. In total, Brazil has recorded 38.9 million cases and 713,000 deaths from COVID-19.

The last two InfoGripe bulletins, published by the Oswaldo Cruz Foundation (Fiocruz) on September 5 and 12, also indicated a long-term upward trend in the number of cases and, consequently, Severe Acute Respiratory Syndrome (SARS) in 17 of the 27 Brazilian states, in particular “due to the large population movement between the state of São Paulo (the most populated state in Brazil and one of the hotspots of the current wave) and other regions of the country.”

InfoGripe’s September 12 newsletter also pointed to a higher incidence of COVID-19 cases and deaths caused by SARS. It reported that 32% of cases and 52% of deaths from SARS in the last four epidemiological weeks were caused by COVID-19, significantly more than those caused by respiratory syncytial virus (9% and 4%), influenza A (14% and 25%), and influenza B (3% and 4%).

According to the Ministry of Health, in 2024 there were about 112,000 hospitalizations and 7,000 deaths due to SARS, 25% of which were due to COVID-19.

COVID-19 is more than just a respiratory illness, though. Growing evidence suggests the devastating impact that SARS-CoV-2 can have on various organs and body systems long after the initial infection, a condition also known as long COVID.

In an interview given in mid-July Capturing BrazilMonica de Bolle, a senior researcher at the Peterson Institute for International Economics and an expert in immunology, said: “SARS-CoV-2 is a systemic virus. It is characterized by respiratory disease, so laypeople understand it as a respiratory virus, but SARS-CoV-2 is not a pure and simple respiratory virus, it settles anywhere in our body.”